EUVIMEDEUVIMED entdecken
Crossref

Development of an assay using a modified coagulation factor V to measure protein S activity

Keiko Maruyama, Koichi Kokame

Journal of Thrombosis and Haemostasis · 2024

DOI: 10.1016/j.jtha.2024.08.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024. Verfasst von Keiko Maruyama und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center, Suita, Japan. Hauptthemen laut MEDLINE: Protein S, Blood Coagulation, Protein C, Protein S Deficiency. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Government of Japan Ministry of Health Labour and Welfare, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Protein S (PS) is an anticoagulant that functions as a cofactor for activated protein C and the tissue factor pathway inhibitor. PS deficiency is a risk factor for venous thromboembolism. PS activity is commonly measured using clot-based assays involving fibrin and thrombin production, but improvements are needed. OBJECTIVES: To develop a new assay for measuring plasma PS activity by quantifying the amount of activated coagulation factor (F)V cleaved by activated protein C. METHODS: We designed a recombinant, modified FV (FVm) that mimicked FVa. We analyzed 160 purposively selected plasma samples from the Biobank of the National Cerebral and Cardiovascular Center. RESULTS: The assay using mixed normal and PS-deficient plasma detected FVm cleavage in a PS concentration-dependent manner. The correlation between PS activity, measured using the FVm cleavage assay, and free PS antigen levels was relatively weak. We then sequenced all exons of PROS1 from 47 subjects with

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein SBlood CoagulationProtein CProtein S DeficiencyHumansBlood Coagulation TestsRecombinant ProteinsFactor VFemaleMaleReproducibility of ResultsPredictive Value of TestsExons

Stichwörter der Autor:innen

factor Vprotein Cprotein Svenous thromboembolism

Substanzen

Protein SPROS1 protein, humanProtein CRecombinant ProteinsFactor V

Autor:innen und Institutionen

  • Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center, Suita, Japan.
  • Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center, Suita, Japan. Electronic address: kame@ncvc.go.jp.

Förderung

  • Government of Japan Ministry of Health Labour and Welfare
  • Japan Society for the Promotion of Science

Zitieren

APA

Maruyama, K., & Kokame, K. (2024). Development of an assay using a modified coagulation factor V to measure protein S activity. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.08.010

Vancouver

Maruyama K, Kokame K. Development of an assay using a modified coagulation factor V to measure protein S activity. Journal of Thrombosis and Haemostasis. 2024. doi:10.1016/j.jtha.2024.08.010

BibTeX
@article{Maruyama2024,
  author = {Maruyama, Keiko and Kokame, Koichi},
  title = {Development of an assay using a modified coagulation factor V to measure protein S activity},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2024},
  doi = {10.1016/j.jtha.2024.08.010}
}
Kostenlos starten →